While this percentage might seem small, it is significant enough to warrant attention
What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge Editorial Note This brief was updated on May 11, 2026 to reflect changes in the Trump administrations plans for implementation of the BALANCE Model in Medicare and an extension of the Medicare GLP-1 Bridge program through 2027
Founded by Mary Bycholski, APRN , a board-certified Nurse Practitioner with over a decade of experience in internal medicine, emergency care, and neurology, the practice combines advanced medical expertise with a preventative approach to health
In practical terms: for every 100 high-risk patients like those in the trial treated for several years, about two major cardiovascular events were prevented
however, GLP-1 receptor agonists (GLP-1RAs) have been developed to prolong its activity and maximize its metabolic benefits
Last updated May 2026
